UN

UnitedHealth Group Incorporated

UNHHealthcareNASDAQ

Healthcare Plans · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$447.57B
+11.8% YoY
Net Income
$12.06B
-16.3% YoY
EBITDA
$23.06B
-17.9% YoY
Free Cash Flow
$26.50B

Scan Results

Daily timeframe
15 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 16CONFIRMED▼ RSI OverboughtRSI 70.4, above 70, stock may be overbought
Oct 9▲ Above MA150+0.2% from MA150, price crossed above
About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company carries a $375.28B market cap, placing it firmly in the mega-cap category. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.

Where UNH stands vs its 150-day and 200-day moving averages

As of the October 16, 2026 close, UNH finished 8.78% above its 150-day moving average ($373.83) and 14.48% above its 200-day moving average ($355.24). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is UNH overbought or oversold?

At the October 16, 2026 close, UNH's RSI(14) was 70.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$375.28B
P/E (TTM)26.89
Fwd P/E17.96
EPS$15.55
Beta0.61
52W Change+14.2%
Dividend Yield2.22%
ROE15.8%
Analysis

On the balance sheet, UNH has $28.55B in cash with $74.33B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $26.50B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 15.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $324.16B (2022) to $447.57B (2025), reflecting a 38% increase over the period.

The relatively low beta of 0.61 suggests UNH is a less volatile holding compared to the broader index. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for UnitedHealth Group Incorporated and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms